Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

6082 ARTÍCULOS , VIENDO DEL 1486 AL 1500

α-Klotho as a central integrative signalling hub in cognitive function and neuroprotection in neurodegenerative diseases

Bindal P, Kuwar OK, Singh VK, Attri M, Pallavi, Tejpal S.

Metab Brain Dis. 2026 Jun 11;41(1):133. doi: 10.1007/s11011-026-01897-7.

Environmental Factors Drive Neurodegenerative Diseases Through Glutamate Excitotoxicity: A Convergent Mechanistic Pathway

He Y, Yi T, Min M, Xu K, Lin H, Xu R, Deng D, Xiao X.

Neurosci Bull. 2026 Jun 11. doi: 10.1007/s12264-026-01645-y. Online ahead of print.

The Role of Serotonergic System in Parkinson's Disease-Related Pain

Song YZ, Shen YQ.

Neurosci Bull. 2026 Jun 11. doi: 10.1007/s12264-026-01649-8. Online ahead of print.

State-of-the-Art Imaging and Localization Assessment in Post-Operative Deep Brain Stimulation for Parkinson's Disease: A Review

Susanto KT, Premchand B, Wan KR, Yu WY, Oh HP, Chan VEY, Misbaah F, So RQ.

Stereotact Funct Neurosurg. 2026 Jun 11:1-13. doi: 10.1159/000553009. Online ahead of print.

Is Parkinson's really a disease? Reframing it as a phenotype of aging

Dashtipour K.

Parkinsonism Relat Disord. 2026 Aug;149:108387. doi: 10.1016/j.parkreldis.2026.108387. Epub 2026 Jun 9.

A treadmill training program in a gamified virtual reality environment combined with transcranial direct current stimulation in Parkinson's Disease: Preliminary results of a mixed methods randomized controlled trial

Bosch-Barceló P, Tersa-Miralles C, Martínez-Navarro O, Masbernat-Almenara M, Pakarinen A, Fernández-Lago H.

Neurol Sci. 2026 Jun 12;47(7):564. doi: 10.1007/s10072-026-09136-8.

Stem Cell Therapy for Parkinson's Disease: A Mechanistically Distinct Role for Muse Cells

Mesches MH, Granholm AC, Paredes D, Mesches K, Oguma Y, Dezawa M.

J Clin Med. 2026 Jun 5;15(11):4370. doi: 10.3390/jcm15114370.

Herbal Neurotherapeutics for Cognitive Disorders: Integrative Mechanisms Linking Neurotransmitter Systems, Neurodegeneration, and the Gut-Brain Axis

Rahman M, Akter K, Rani A, Park MN, Kim B.

Nutrients. 2026 Jun 2;18(11):1796. doi: 10.3390/nu18111796.

The Role of the IL-33/ST2 Axis in Nervous System Development and Diseases

Luo Z, Yang J.

Immunol Cell Biol. 2026 Aug;104(7):671-681. doi: 10.1111/imcb.70138. Epub 2026 Jun 11.

A genome-wide association study of young onset Parkinson's disease in European ancestry

Lie IH, van Wetering J, Valori M, Brolin KA, Step K, Schulte C, Iwaki H, Bandres-Ciga S, Leonard H, Sharma M; International Parkinson’s Disease Genomics Consortium; Global Parkinson’s Genetics Program; Singleton A, Pihlstrøm L.

medRxiv [Preprint]. 2026 Jun 4:2026.06.03.26354799. doi: 10.64898/2026.06.03.26354799.

HFE genotype influences substantia nigra iron accumulation and Parkinson's disease progression

Du G, Wang E, Sica C, Stone R, De Jesus S, Kong L, Mailman RB, Huang X.

medRxiv [Preprint]. 2026 Jun 3:2026.06.02.26354750. doi: 10.64898/2026.06.02.26354750.

Longitudinal changes of iron in the substantia nigra of early-stage Parkinson's disease

Du G, Sica C, De Jesus S, Kong L, Mailman RB, Huang X.

medRxiv [Preprint]. 2026 Jun 3:2026.06.02.26354736. doi: 10.64898/2026.06.02.26354736.

Structural basis for regulation of the proteasome 20S core particle by the Parkinsonism-associated proteins FBXO7 and PI31

Adolf F, Goodall EA, Singh E, von Gronau S, Perez EF, Fung D, Müller B, Paulo JA, Hanna J, Harper JW, Schulman BA.

bioRxiv [Preprint]. 2026 Jun 4:2026.05.28.728263. doi: 10.64898/2026.05.28.728263.

Levodopa increases substantia nigra iron: implications for Parkinson's disease

Du G, Bransom L, Zhou M, Sica C, Huang X, Yang Y, Mailman RB.

bioRxiv [Preprint]. 2026 Jun 1:2026.05.26.728066. doi: 10.64898/2026.05.26.728066.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias